Justin Greaves scored a Test career-high 202 not out as West Indies made the second-highest fourth-innings total in history to earn a draw with New Zealand in the series opener in Christchurch.
West Indies had been skittled for just 167 in their…

Justin Greaves scored a Test career-high 202 not out as West Indies made the second-highest fourth-innings total in history to earn a draw with New Zealand in the series opener in Christchurch.
West Indies had been skittled for just 167 in their…

Liver diseases remain a significant global health challenge, contributing to approximately 2 million deaths every year and accounting for nearly 4% of all global deaths.1 Chronic liver conditions such as cirrhosis, hepatitis B and C…

Liver health is critical to overall wellness, yet liver disorders are increasingly common, often leaving patients feeling anxious and unsure about the future. One such inspiring journey comes from a 41-year-old patient who had been struggling…

Invasive meningococcal disease (IMD) is caused by Neisseria meningitidis (Nm), which is ranked as the first pathogen in the World Health Organization (WHO) roadmap for defeating meningitis by 2030.1 According to the capsular…

Most children have smart phones these days. While a lot of times, smartphones are handy in keeping children safe (through regular contact, tracking etc.), giving them too early to your child can cause a host of issues, says science. Let’s see…


Bladder cancer (BCa), a prevalent malignant tumor in the urinary system,1 poses significant health challenges. For non-muscle-invasive bladder cancer and cases with high risks of recurrence and progression, postoperative…

Recent remarks from MarketAxess Holdings (MKTX) at the Barclays Financial Services Conference put a spotlight on its next phase of growth, including deeper automation, non U.S. credit expansion and emerging markets opportunities.
See our latest analysis for MarketAxess Holdings.
Even with these growth levers, the 1 year total shareholder return of negative 29.18 percent and 3 year total shareholder return of negative 38.11 percent show longer term momentum has faded, despite a modest recent recovery in the 30 day share price return of 3.88 percent from a last close of 167.24 dollars.
If you like the MarketAxess story but want more ideas in financial technology, this could be a good moment to explore fast growing stocks with high insider ownership.
With revenues and profits still growing, but the share price languishing well below past highs and roughly 20 percent under the average analyst target, is MarketAxess now a mispriced compounder, or is the market correctly discounting its future growth?
With MarketAxess last closing at 167.24 dollars, the most followed narrative points to a materially higher fair value anchored around future earnings power.
The analysts have a consensus price target of 218.833 dollars for MarketAxess Holdings based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of 274.0 dollars, and the most bearish reporting a price target of just 168.0 dollars.
Read the complete narrative.
Curious how a steady revenue glide path, rising margins and a premium earnings multiple combine into that fair value? The narrative lifts the lid on those projections, but keeps the boldest assumptions just out of view until you dive in.
Result: Fair Value of $200.90 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, that upside case could unravel if competitive pressure intensifies and high grade block trades remain stubbornly phone based, limiting electronic share gains.
Find out about the key risks to this MarketAxess Holdings narrative.
Step away from analyst targets and the picture looks quite different. On a price to earnings basis of 28.3 times versus a fair ratio of 14.9 times, and above both industry and peer averages, MarketAxess screens as expensive. Is the market overpaying for quality, or just pricing in reality?
See what the numbers say about this price — find out in our valuation breakdown.